TY - JOUR
T1 - Early nephrologist involvement in Hospital-acquired acute kidney injury
T2 - A pilot study
AU - Balasubramanian, Geetha
AU - Al-Aly, Ziyad
AU - Moiz, Abdul
AU - Rauchman, Michael
AU - Zhang, Zhiwei
AU - Gopalakrishnan, Rajalakshmi
AU - Balasubramanian, Sumitra
AU - El-Achkar, Tarek M.
N1 - Funding Information:
Support: Dr El-Achkar is supported by a Norman Coplon Grant from Satellite Healthcare .
PY - 2011/2
Y1 - 2011/2
N2 - Background The optimal timing of nephrology consultation in patients with hospital-acquired acute kidney injury (AKI) is unknown. Study Design Prospective controlled nonrandomized intervention study. Setting & Participants We screened daily serum creatinine (SCr) levels of 4,296 patients admitted to the St. Louis Veterans Affairs Medical Center between September and November 2008 (control group) and January to May 2009 (intervention group). 354 patients (8.2%) met the definition of in-hospital AKI (SCr level increase of 0.3 mg/dL over 48 hours); 176 of whom met all inclusion criteria; 85 and 91 patients were enrolled in the control (standard care) and intervention groups, respectively. Intervention Early renal service involvement (EARLI), defined as a 1-time nephrology consultation within 18 hours of the onset of AKI. Outcome Primary outcome defined as 2.5-fold increase in SCr level from admission. Measurement Daily SCr until discharge. Results The 2 groups had similar characteristics at baseline and at the time of AKI. The intervention was completed at a mean of 13.1 ± 0.8 hours from the onset of AKI. Nephrology recommendations in the EARLI group included specific diagnostic, therapeutic, and preventative components. The primary outcome occurred in 12.9% of patients in the control group compared with 3.3% of patients in the EARLI group (P = 0.02). Patients in the EARLI group had a lower peak SCr level of 1.8 ± 0.1 versus 2.1 ± 0.2 mg/dL in controls (P = 0.01). Limitations Single-center nonrandomized study of mostly US male veterans. Conclusions Early nephrologist involvement in patients with AKI may reduce the risk of a further decrease in kidney function. A larger randomized trial is needed to confirm the findings.
AB - Background The optimal timing of nephrology consultation in patients with hospital-acquired acute kidney injury (AKI) is unknown. Study Design Prospective controlled nonrandomized intervention study. Setting & Participants We screened daily serum creatinine (SCr) levels of 4,296 patients admitted to the St. Louis Veterans Affairs Medical Center between September and November 2008 (control group) and January to May 2009 (intervention group). 354 patients (8.2%) met the definition of in-hospital AKI (SCr level increase of 0.3 mg/dL over 48 hours); 176 of whom met all inclusion criteria; 85 and 91 patients were enrolled in the control (standard care) and intervention groups, respectively. Intervention Early renal service involvement (EARLI), defined as a 1-time nephrology consultation within 18 hours of the onset of AKI. Outcome Primary outcome defined as 2.5-fold increase in SCr level from admission. Measurement Daily SCr until discharge. Results The 2 groups had similar characteristics at baseline and at the time of AKI. The intervention was completed at a mean of 13.1 ± 0.8 hours from the onset of AKI. Nephrology recommendations in the EARLI group included specific diagnostic, therapeutic, and preventative components. The primary outcome occurred in 12.9% of patients in the control group compared with 3.3% of patients in the EARLI group (P = 0.02). Patients in the EARLI group had a lower peak SCr level of 1.8 ± 0.1 versus 2.1 ± 0.2 mg/dL in controls (P = 0.01). Limitations Single-center nonrandomized study of mostly US male veterans. Conclusions Early nephrologist involvement in patients with AKI may reduce the risk of a further decrease in kidney function. A larger randomized trial is needed to confirm the findings.
KW - Acute kidney injury
KW - nephrology consultation
UR - http://www.scopus.com/inward/record.url?scp=78751631543&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2010.08.026
DO - 10.1053/j.ajkd.2010.08.026
M3 - Article
C2 - 21195518
AN - SCOPUS:78751631543
SN - 0272-6386
VL - 57
SP - 228
EP - 234
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 2
ER -